Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity

A Puel, S Cypowyj, J Bustamante, JF Wright, L Liu… - Science, 2011 - science.org
A Puel, S Cypowyj, J Bustamante, JF Wright, L Liu, HK Lim, M Migaud, L Israel, M Chrabieh…
Science, 2011science.org
Chronic mucocutaneous candidiasis disease (CMCD) is characterized by recurrent or
persistent infections of the skin, nails, and oral and genital mucosae caused by Candida
albicans and, to a lesser extent, Staphylococcus aureus, in patients with no other infectious
or autoimmune manifestations. We report two genetic etiologies of CMCD: autosomal
recessive deficiency in the cytokine receptor, interleukin-17 receptor A (IL-17RA), and
autosomal dominant deficiency of the cytokine interleukin-17F (IL-17F). IL-17RA deficiency …
Chronic mucocutaneous candidiasis disease (CMCD) is characterized by recurrent or persistent infections of the skin, nails, and oral and genital mucosae caused by Candida albicans and, to a lesser extent, Staphylococcus aureus, in patients with no other infectious or autoimmune manifestations. We report two genetic etiologies of CMCD: autosomal recessive deficiency in the cytokine receptor, interleukin-17 receptor A (IL-17RA), and autosomal dominant deficiency of the cytokine interleukin-17F (IL-17F). IL-17RA deficiency is complete, abolishing cellular responses to IL-17A and IL-17F homo- and heterodimers. By contrast, IL-17F deficiency is partial, with mutant IL-17F–containing homo- and heterodimers displaying impaired, but not abolished, activity. These experiments of nature indicate that human IL-17A and IL-17F are essential for mucocutaneous immunity against C. albicans, but otherwise largely redundant.
AAAS